Carl Co

Company: Arbor Biotechnologies

Job title: Senior Director - Analytical Sciences

Seminars:

Regulatory Readiness for the Analytical Development of CRISPR-Edited Products 10:00 am

This workshop will delve into the regulatory landscape for CRISPR-based therapies, highlighting new trials, case studies, and lessons from IND submissions. Participants will gain valuable insights into FDA guidelines, quality assurance practices, and regulatory requirements for both in vivo and in vitro CRISPR-based therapeutics. Discussions will focus on maintaining regulatory consistency, anticipating changes, and ensuring…Read more

day: Pre-Conference Day

Panel Discussion: Evolving Perspectives on Delivery Vehicles & the Impact on CRISPR-Edited Therapies’ Analytical Development 12:00 pm

Assessing the performance of various novel delivery systems in delivering CRISPR components, ensuring optimal therapeutic outcomes Identifying and addressing the barriers to effective delivery, including immune response, off-target effects, and delivery efficiency, to enhance the precision and safety of CRISPR-edited therapies What are the most promising delivery vehicles currently being developed?Read more

day: Conference Day One